ERK1/2 is a marker of cancer progress; it has a role in cell survival, growth regulation, proliferation, apoptosis and cell cycle’s G1- to S-phase progression (Lu & Xu, 2006; Meloche & Pouyssegur, 2007). This evidence concerns the gene MAPK3 and cancer.